Home » Topics » Regulatory

Regulatory
RSS

Vaniqa approved by FDA for women with unwanted facial hair

Aug. 2, 2000

No Comments

Celecoxib in familial adenomatous polyposis

Aug. 1, 2000

No Comments

Cimetidine as treatment for viral warts in children and adults

Aug. 1, 2000

No Comments

Anticancer combinations with synergistic activity

July 31, 2000

No Comments

Methods of treating CFS with 5-HT3 antagonists described by Novartis

July 31, 2000

No Comments

Combined AT1 antagonist and immunosuppressant for GvHD complications

July 31, 2000

No Comments

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

July 31, 2000

No Comments

New dosage form, indication approved for Bayer's cerivastatin

July 28, 2000

No Comments

Abbot's divalproex newly formulated for once-daily dosing

July 27, 2000

No Comments

Topically applied GAG synthesis inhibitors useful for corneal haze

July 27, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Vaniqa approved by FDA for women with unwanted facial hair

Celecoxib in familial adenomatous polyposis

Cimetidine as treatment for viral warts in children and adults

Anticancer combinations with synergistic activity

Methods of treating CFS with 5-HT3 antagonists described by Novartis

Combined AT1 antagonist and immunosuppressant for GvHD complications

Tetracyclines as a valuable and relatively safe therapy for corneal ulceration

New dosage form, indication approved for Bayer's cerivastatin

Abbot's divalproex newly formulated for once-daily dosing

Topically applied GAG synthesis inhibitors useful for corneal haze

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Regulatory RSS

Regulatory
RSS